Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Association of Mesopic Visual Sensitivities with automatically segmented Retinal Pigment Epithelium and Outer Retinal Atrophy (RORA) on Ocular Coherence Tomography (OCT)
Author Affiliations & Notes
  • Ana Paula Ribeiro Reis
    Reading Centre and Clinical AI Lab, Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
    NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom
  • Taha Soomro
    Reading Centre and Clinical AI Lab, Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
    NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom
  • Dun Jack Fu
    Reading Centre and Clinical AI Lab, Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
    NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom
  • Gunjan Naik
    Reading Centre and Clinical AI Lab, Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
    NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom
  • Gongyu Zhang
    Reading Centre and Clinical AI Lab, Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
    NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom
  • Alan Sousa da Silva
    Reading Centre and Clinical AI Lab, Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
    NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom
  • Ismail Moghul
    Reading Centre and Clinical AI Lab, Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
    NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom
  • Pallavi Bagga
    Reading Centre and Clinical AI Lab, Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
    NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom
  • Praveen J Patel
    NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom
  • Nikolas Pontikos
    Institute of Ophthalmology, University College London, London, United Kingdom
    Reading Centre and Clinical AI Lab, Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
  • Robyn H Guymer
    Ophthalmology, Department of Surgery, The University of Melbourne, Melbourne, Victoria, Australia
    Centre for Eye Research Australia (CERA), The Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia
  • Zhichao Wu
    Ophthalmology, Department of Surgery, The University of Melbourne, Melbourne, Victoria, Australia
    Centre for Eye Research Australia (CERA), The Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia
  • Konstantinos Balaskas
    Reading Centre and Clinical AI Lab, Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
    NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom
  • Footnotes
    Commercial Relationships   Ana Paula Ribeiro Reis None; Taha Soomro None; Dun Jack Fu AbbVie, Allergan, DeepMind, Code C (Consultant/Contractor); Gunjan Naik None; Gongyu Zhang None; Alan Sousa da Silva None; Ismail Moghul Phenopolis Ltd, Code O (Owner); Pallavi Bagga None; Praveen Patel Bayer, Roche, Code C (Consultant/Contractor), Bayer, Roche, Code R (Recipient); Nikolas Pontikos NIHR AI Awardee (AI_AWARD02488), Code F (Financial Support), Phenopolis Ltd, Code O (Owner); Robyn Guymer Roche, Genentech, Apellis, Novartis, Bayer, Belite, AbbVie, Janssen, Code C (Consultant/Contractor); Zhichao Wu None; Konstantinos Balaskas Novartis, Roche, Code C (Consultant/Contractor), Novartis, Bayer, Alimera, Allergan, Roche, Heidelberg, Code R (Recipient)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 3760. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ana Paula Ribeiro Reis, Taha Soomro, Dun Jack Fu, Gunjan Naik, Gongyu Zhang, Alan Sousa da Silva, Ismail Moghul, Pallavi Bagga, Praveen J Patel, Nikolas Pontikos, Robyn H Guymer, Zhichao Wu, Konstantinos Balaskas; Association of Mesopic Visual Sensitivities with automatically segmented Retinal Pigment Epithelium and Outer Retinal Atrophy (RORA) on Ocular Coherence Tomography (OCT). Invest. Ophthalmol. Vis. Sci. 2024;65(7):3760.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Monitoring vision in age-related macular degeneration (AMD) is challenging and emerging treatments are driving demand for new functional biomarkers. To address this, we explored the association between mesopic visual sensitivities and RORA OCT-defined features in intermediate AMD, with an externally validated deep-learning segmentation model.

Methods : We analyzed 285 individuals from the Laser Intervention in Early Stages of AMD (LEAD) trial, aged 50 and above, with intermediate AMD at baseline. OCT and microperimetry were part of the study protocol. RORA features (photoreceptor degeneration [PRD], retinal pigment epithelium [RPE] loss, and choroidal hypertransmission [HT]) were segmented by the U-Net-based model from Zhang et al. on a B-scan level. PRD in isolation excluded overlapping RPE loss or HT. Segmentations were projected on the near-infrared (NIR) and matched the five sectors in the central 3.6-mm region sampled on microperimetry (figure 1). Multivariable linear mixed models explored the association of sectoral-mesopic visual sensitivity with sectoral-OCT RORA features in one model, and its individual features in another. These models were adjusted for age, OCT-sectoral drusen volume, and total reticular pseudodrusen area, calculated as previously reported in this cohort (Kumar et al, IOVS, 2022).

Results : 285 participants, 79% women and a mean age of 70±8 years, were included. Both RORA (-2.92 μm, 95%CI -3.90,-1.94, p<0.001) and its features: (PRD [-0.54 μm, 95% CI -0.85, -0.23, p=0.001] and RPE loss [-1.45μm, 95%CI -2.19, -0.70, p=<0.001]) were independently associated with sectoral visual sensitivity. HT and PRD in isolation showed no significant association (P > 0.01).

Conclusions : The increasing spatial extent of sectoral RORA on OCT as segmented by a machine learning model is associated with worsening mesopic visual sensitivities. Our findings indicate that the automatically segmented morphological features of intermediate AMD are related to function and lay the groundwork for future studies.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

FIGURE 1
A) Non-segmented OCT B-scan with RORA
B) Segmented B-scan: PRD (yellow), RPE loss (green), and HT (blue). Composite of RORA and PRD in isolation in bounding boxes
C) En face projection of B-scan segmentation on NIR, matching microperimetry grid.
D) Microperimetry testing stimulus pattern combined with image 1B

FIGURE 1
A) Non-segmented OCT B-scan with RORA
B) Segmented B-scan: PRD (yellow), RPE loss (green), and HT (blue). Composite of RORA and PRD in isolation in bounding boxes
C) En face projection of B-scan segmentation on NIR, matching microperimetry grid.
D) Microperimetry testing stimulus pattern combined with image 1B

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×